Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Else A. Aalbersberg*, Daphne M. V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P. M. Stokkel, Richard P. Baum

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1259-1265
Number of pages7
JournalJournal of Nuclear Medicine
Volume60
Issue number9
DOIs
Publication statusPublished - 1 Sep 2019

Keywords

  • DISEASE
  • EFFICACY
  • ENETS CONSENSUS GUIDELINES
  • LU-177-OCTREOTATE
  • METASTATIC NICHE
  • NEOPLASMS
  • NEUROENDOCRINE TUMORS
  • PRRT
  • TOLERABILITY
  • TRACERS
  • multivariate analysis
  • neuroendocrine tumor

Cite this

Aalbersberg, Else A. ; Huizing, Daphne M. V. ; Walraven, Iris ; de Wit-van der Veen, Berlinda J. ; Kulkarni, Harshad R. ; Singh, Aviral ; Stokkel, Marcel P. M. ; Baum, Richard P. / Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy : A Multivariate Analysis in 782 Patients. In: Journal of Nuclear Medicine. 2019 ; Vol. 60, No. 9. pp. 1259-1265.
@article{8321edb58a7d403fa5abf4e52791b9ec,
title = "Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients",
keywords = "DISEASE, EFFICACY, ENETS CONSENSUS GUIDELINES, LU-177-OCTREOTATE, METASTATIC NICHE, NEOPLASMS, NEUROENDOCRINE TUMORS, PRRT, TOLERABILITY, TRACERS, multivariate analysis, neuroendocrine tumor",
author = "Aalbersberg, {Else A.} and Huizing, {Daphne M. V.} and Iris Walraven and {de Wit-van der Veen}, {Berlinda J.} and Kulkarni, {Harshad R.} and Aviral Singh and Stokkel, {Marcel P. M.} and Baum, {Richard P.}",
year = "2019",
month = "9",
day = "1",
doi = "10.2967/jnumed.118.224386",
language = "English",
volume = "60",
pages = "1259--1265",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine and Molecular Imaging",
number = "9",

}

Aalbersberg, EA, Huizing, DMV, Walraven, I, de Wit-van der Veen, BJ, Kulkarni, HR, Singh, A, Stokkel, MPM & Baum, RP 2019, 'Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients', Journal of Nuclear Medicine, vol. 60, no. 9, pp. 1259-1265. https://doi.org/10.2967/jnumed.118.224386

Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy : A Multivariate Analysis in 782 Patients. / Aalbersberg, Else A.; Huizing, Daphne M. V.; Walraven, Iris; de Wit-van der Veen, Berlinda J.; Kulkarni, Harshad R.; Singh, Aviral; Stokkel, Marcel P. M.; Baum, Richard P.

In: Journal of Nuclear Medicine, Vol. 60, No. 9, 01.09.2019, p. 1259-1265.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy

T2 - A Multivariate Analysis in 782 Patients

AU - Aalbersberg, Else A.

AU - Huizing, Daphne M. V.

AU - Walraven, Iris

AU - de Wit-van der Veen, Berlinda J.

AU - Kulkarni, Harshad R.

AU - Singh, Aviral

AU - Stokkel, Marcel P. M.

AU - Baum, Richard P.

PY - 2019/9/1

Y1 - 2019/9/1

KW - DISEASE

KW - EFFICACY

KW - ENETS CONSENSUS GUIDELINES

KW - LU-177-OCTREOTATE

KW - METASTATIC NICHE

KW - NEOPLASMS

KW - NEUROENDOCRINE TUMORS

KW - PRRT

KW - TOLERABILITY

KW - TRACERS

KW - multivariate analysis

KW - neuroendocrine tumor

U2 - 10.2967/jnumed.118.224386

DO - 10.2967/jnumed.118.224386

M3 - Article

VL - 60

SP - 1259

EP - 1265

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 9

ER -